In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges

References

• Esfahani K, Roudaia L, Buhlaiga N, et al. A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol [Internet]. 2020. [cited 2023 Nov 3];27(12):S87–97. Available from: /pmc/articles/PMC7194005/. doi: 10.3747/co.27.5223
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov [Internet]. 2022 [cited 2022 Jan 30];12(1):31–46. doi: 10.1158/2159-8290.CD-21-1059.
   PubMed Web of Science ®Google Scholar
• Brahmer JR, Abu-Sbeih H, Ascierto PA, et al. Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer [Internet]. 2021 [cited 2023 May 16];9(6):e002435. doi: 10.1136/jitc-2021-002435
   PubMed Web of Science ®Google Scholar
• Shields MD, Marin-Acevedo JA, Pellini B. Immunotherapy for advanced non–small cell lung cancer: a decade of progress. Am Soc Clin Oncol Educ Book [Internet]. 2021 [cited 2023 Nov 9];41(41):e105–e127. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33979196. doi: 10.1200/EDBK_321483
   Google Scholar
• Thapa B, Roopkumar J, Kim AS, et al. Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). 2019;37:e14151–e14151.
   Google Scholar
• Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma. J Clin Oncol. 2022;40(2):127–137. doi: 10.1200/JCO.21.02229
   PubMed Web of Science ®Google Scholar
• Arnaud-Coffin P, Maillet D, Gan HK, et al. A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. Int J Cancer [Internet]. 2019 [cited 2023 May 16];145(3):639–648. doi: 10.1002/ijc.32132
   PubMed Web of Science ®Google Scholar
• Horn LA, Fousek K, Palena C. Tumor plasticity and resistance to immunotherapy. Trends Cancer [Internet]. 2020 [cited 2023 Nov 2];6(5):432. Available from: /pmc/articles/PMC7192950/. doi: 10.1016/j.trecan.2020.02.001
   PubMed Web of Science ®Google Scholar
• Sharma P, Hu-Lieskovan S, Wargo JA, et al. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707–723. doi: 10.1016/j.cell.2017.01.017
   PubMed Web of Science ®Google Scholar
• Sankar K, Ye JC, Li Z, et al. The role of biomarkers in personalized immunotherapy. Biomark Res [Internet]. 2022 [cited 2024 Feb 11];10(1):1–13. doi: 10.1186/s40364-022-00378-0
   PubMed Web of Science ®Google Scholar
• Meijer TG, Naipal KA, Jager A, et al. Ex vivo tumor culture systems for functional drug testing and therapy response prediction. Future Sci OA [Internet]. 2017. cited 2022 Jan 22;3(2):FSO190. Available from: /pmc/articles/PMC5481868/. doi: 10.4155/fsoa-2017-0003
   PubMed Web of Science ®Google Scholar
• Mason J, D Ö. Key aspects for conception and construction of co-culture models of tumor-stroma interactions. Front Bioeng Biotechnol. 2023;11:1150764. doi: 10.3389/fbioe.2023.1150764
   PubMed Web of Science ®Google Scholar
• Hickman JA, Graeser R, de Hoogt R, et al. Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo. Biotechnol J [Internet]. 2014 [cited 2024 Feb 11];9(9):1115–1128. doi: 10.1002/biot.201300492
   PubMed Web of Science ®Google Scholar
• Du Y, Li X, Niu Q, et al. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. J Mol Cell Biol [Internet] 2020 [cited 2024 Feb 11];12:630. Available from: /pmc/articles/PMC7751183/. doi: 10.1093/jmcb/mjaa036.
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol [Internet]. 2003 [cited 2024 Feb 8];15(6):753. Available from: /pmc/articles/PMC2933200/. doi: 10.1016/j.ceb.2003.10.016
   PubMed Web of Science ®Google Scholar
• Meyers J, Craig J, Odde DJJ. Potential for control of signaling pathways via cell size and shape. Curr Biol [Internet]. 2006 [cited 2024 Feb 8]. 16(17):1685–1693. doi: 10.1016/j.cub.2006.07.056.
   PubMed Web of Science ®Google Scholar
• Mseka T, Bamburg JR, Cramer LP. Adf/cofilin family proteins control formation of oriented actin-filament bundles in the cell body to trigger fibroblast polarization. J Cell Sci [Internet]. 2007 [cited 2024 Feb 8]. 120(24):4332–4344. doi: 10.1242/jcs.017640.
   PubMed Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer [Internet]. 2005 [cited 2024 Feb 8]. 5(9):675–688. doi: 10.1038/nrc1695.
   PubMed Web of Science ®Google Scholar
• Mahmud G, Campbell CJ, Bishop KJM, et al. Directing cell motions on micropatterned ratchets. Nat Phys [Internet]. 2009. cited 2024 Feb 8;5(8):606–612. Available from: https://www.nature.com/articles/nphys1306. doi: 10.1038/nphys1306
   Web of Science ®Google Scholar
• Melissaridou S, Wiechec E, Magan M, et al. The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer Cell Int [Internet]. 2019 [cited 2024 Feb 8];19(1):1–10. doi: 10.1186/s12935-019-0733-1
   PubMedGoogle Scholar
• Zschenker O, Streichert T, Hehlgans S, et al. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS One [Internet]. 2012 [cited 2024 Feb 8];7(4):e34279. doi: 10.1371/journal.pone.0034279
   PubMed Web of Science ®Google Scholar
• Krysko DV, Demuynck R, Efimova I, et al. In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment. Cells [Internet]. 2022. cited 2024 Feb 11;11(22):3705. Available from: https://www.mdpi.com/2073-4409/11/22/3705/htm. doi: 10.3390/cells11223705
   PubMed Web of Science ®Google Scholar
• Stock K, Estrada MF, Vidic S, et al. Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep [Internet]. 2016 [cited 2024 Feb 11];6(1). Available from: /pmc/articles/PMC4929472/. doi: 10.1038/srep28951
   Google Scholar
• Mo X, Tang C, Niu Q, et al. HTiP: high-throughput immunomodulator phenotypic screening platform to reveal IAP antagonists as anti-cancer immune enhancers. Cell Chem Biol. 2019;26(3):331–339.e3. doi: 10.1016/j.chembiol.2018.11.011
   PubMed Web of Science ®Google Scholar
• Mackenzie NJ, Nicholls C, Templeton AR, et al. Modelling the tumor immune microenvironment for precision immunotherapy. Clin Transl Immunology [Internet]. 2022 [cited 2024 Feb 11];11(6):e1400. doi: 10.1002/cti2.1400
   PubMed Web of Science ®Google Scholar
• Olivo Pimentel V, Yaromina A, Marcus D, et al. A novel co-culture assay to assess anti-tumor CD8+ T cell cytotoxicity via luminescence and multicolor flow cytometry. J Immunol Methods. 2020;487:112899. doi: 10.1016/j.jim.2020.112899
   PubMed Web of Science ®Google Scholar
• Rodrigues J, Heinrich MA, Teixeira LM, et al. 3D in vitro model (R)evolution: unveiling tumor–stroma interactions. Trends Cancer. 2021;7(3):249–264. doi: 10.1016/j.trecan.2020.10.009
   PubMed Web of Science ®Google Scholar
• Campuzano S, Pelling AE. Scaffolds for 3D cell culture and cellular agriculture applications derived from non-animal sources. Front Sustain Food Syst. 2019;3:38. doi: 10.3389/fsufs.2019.00038
   Google Scholar
• Weiswald LB, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia. 2015;17(1):1–15. doi: 10.1016/j.neo.2014.12.004
   PubMed Web of Science ®Google Scholar
• Mäkelä R, Arjonen A, Härmä V, et al. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. BMC Cancer [Internet] 2020 [cited 2021 Oct 3];20:1–10. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07092-w. doi: 10.1186/s12885-020-07092-w.
   Web of Science ®Google Scholar
• Mönch D, Koch J, Maaß A, et al. A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options. Pleura Peritoneum. 2021;6(3):121–129. doi: 10.1515/pp-2021-0128
   PubMed Web of Science ®Google Scholar
• Tan SQ, Lee Y, Lee FYX, et al. Ex vivo co-culture models for immunotherapy with patient-derived tumor infiltrating lymphocytes, peripheral blood mononuclear cells and autologous patient colorectal cancer (CRC) cell lines. J Clin Oncol. 2018;36(15_suppl):e15531–e15531. doi: 10.1200/JCO.2018.36.15_suppl.e15531
   Web of Science ®Google Scholar
• Gong X, Lin C, Cheng J, et al. Generation of multicellular tumor spheroids with microwell-based agarose scaffolds for drug testing. PLoS One [Internet]. 2015 [cited 2023 Jun 18];10(6):e0130348. doi: 10.1371/journal.pone.0130348
   PubMed Web of Science ®Google Scholar
• Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci [Internet]. 2000 [cited 2023 Jun 18];97:p. 14720–14725. Available from: https://www.pnas.org/doi/abs/10.1073/pnas.97.26.14720.
   Google Scholar
• Kondo J, Endo H, Okuyama H, et al. Retaining cell–cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci U S A [Internet]. 2011. cited 2023 Jun 18;108(15):6235–6240. Available from: https://www.pnas.org/doi/abs/10.1073/pnas.1015938108. doi: 10.1073/pnas.1015938108
   PubMed Web of Science ®Google Scholar
• Burgués JP, Gómez L, Pontones JL, et al. A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. Eur Urol. 2007;51(4):962–970. doi: 10.1016/j.eururo.2006.10.034
   PubMed Web of Science ®Google Scholar
• Powley IR, Patel M, Miles G, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer [Internet]. 2020. cited 2023 Jun 18;122(6):735–744. Available from: https://www.nature.com/articles/s41416-019-0672-6. doi: 10.1038/s41416-019-0672-6
   PubMed Web of Science ®Google Scholar
• Datta P, Dey M, Ataie Z, et al. 3D bioprinting for reconstituting the cancer microenvironment. NPJ Precis Oncol. 2020;4(1):4. doi: 10.1038/s41698-020-0121-2
   PubMed Web of Science ®Google Scholar
• Ruppen J, Wildhaber FD, Strub C, et al. Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform. Lab Chip [Internet]. 2015 [cited 2023 Oct 11];15(14):3076–3085. doi: 10.1039/C5LC00454C
   PubMed Web of Science ®Google Scholar
• Herter S, Morra L, Schlenker R, et al. A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents. Cancer Immunol Immunother [Internet]. 2017 [cited 2023 Nov 28];66(1):129–140. doi: 10.1007/s00262-016-1927-1
   PubMed Web of Science ®Google Scholar
• Tong JG, Valdes YR, Barrett JW, et al. Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis. Mol Ther Oncolytics. 2015;2:15013. doi: 10.1038/mto.2015.13
   PubMed Web of Science ®Google Scholar
• Mukherjee M, Chepizhko O, Chiara Lionetti M, et al. Infiltration of tumor spheroids by activated immune cells. Phys Biol [Internet]. 2023. cited 2023 Nov 28;20(5):056001. Available from: https://iopscience.iop.org/article/10.1088/1478-3975/ace0ee. doi: 10.1088/1478-3975/ace0ee
   Web of Science ®Google Scholar
• He W, Kuang Y, Xing X, et al. Proteomic comparison of 3D and 2D glioma models reveals increased HLA-E expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity. J Proteome Res [Internet]. 2014 [cited 2023 Nov 28];13(5):2272–2281. doi: 10.1021/pr500064m
   PubMed Web of Science ®Google Scholar
• Courau T, Bonnereau J, Chicoteau J, et al. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment. J Immunother Cancer [Internet]. 2019 [cited 2023 Jul 28];7(1):1–14. doi: 10.1186/s40425-019-0553-9
   PubMedGoogle Scholar
• Ou L, Liu S, Wang H, et al. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies. EBioMedicine [Internet]. 2023 [cited 2023 Nov 3];92:104614. Available from: http://www.thelancet.com/article/S2352396423001792/fulltext doi: 10.1016/j.ebiom.2023.104614.
   PubMed Web of Science ®Google Scholar
• Wallstabe L, Göttlich C, Nelke LC, et al. ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models. JCI Insight [Internet]. 2019 [cited 2023 Nov 3];4(18). doi: 10.1172/jci.insight.126345
   PubMed Web of Science ®Google Scholar
• Neal JT, Li X, Zhu J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175(7):1972–1988.e16. doi: 10.1016/j.cell.2018.11.021.
   PubMed Web of Science ®Google Scholar
• Mu H-Y, Lin C-M, Chu L-A, et al. Ex vivo evaluation of combination immunotherapy using tumor-microenvironment-on-chip. Adv Healthc Mater [Internet]. 2023 cited 2023 Nov 3;2302268. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.202302268
   Google Scholar
• Alexander Heinrich M, Bansal R, Lammers T, et al. 3D-Bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics. Adv Mater [Internet]. 2019 [cited 2024 Feb 12];31(14):1806590. doi: 10.1002/adma.201806590
   Web of Science ®Google Scholar
• Maritan SM, Lian EY, Mulligan LM. An efficient and flexible cell aggregation method for 3d spheroid production. J Visualized Exp [Internet]. 2017 cited 2023 Nov 2;2017(121). doi: 10.3791/55544.
   PubMedGoogle Scholar
• Han SJ, Kwon S, Kim KS. Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int [Internet]. 2021 [cited 2023 Jun 19];21(1):1–19. Available from: https://cancerci.biomedcentral.com/articles/10.1186/s12935-021-01853-8. doi: 10.1186/s12935-021-01853-8
   PubMed Web of Science ®Google Scholar
• Barbosa MAG, Xavier CPR, Pereira RF, et al. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers (Basel) [Internet]. 2021 [cited 2023 Jun 19];14(1):190. Available from: http://pmc/articles/PMC8749977/
   PubMed Web of Science ®Google Scholar
• Weiswald LB, Richon S, Validire P, et al. Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. Br J Cancer [Internet]. 2009. cited 2024 Feb 12;101(3):473. Available from: /pmc/articles/PMC2720229/. doi: 10.1038/sj.bjc.6605173
   PubMed Web of Science ®Google Scholar
• Voabil P, de Bruijn M, Roelofsen LM, et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nat Med [Internet]. 2021. cited 2024 Feb 12;27(7):1250–1261. Available from: https://www.nature.com/articles/s41591-021-01398-3. doi: 10.1038/s41591-021-01398-3
   PubMed Web of Science ®Google Scholar
• Mu P, Zhou S, Lv T, et al. Newly developed 3D in vitro models to study tumor–immune interaction. J Exp Clin Cancer Res [Internet]. 2023 [cited 2024 Feb 12];42(1):1–16. doi: 10.1186/s13046-023-02653-w
   PubMed Web of Science ®Google Scholar
• Demers I, Donkers J, Kremer B, et al. Ex vivo culture models to indicate therapy response in head and neck squamous cell carcinoma. Cells [Internet]. 2020. cited 2022 Jan 31;9(11):2527. Available from: /pmc/articles/PMC7700693/. doi: 10.3390/cells9112527
   PubMed Web of Science ®Google Scholar
• Subia B, Dahiya UR, Mishra S, et al. Breast tumor-on-chip models: from disease modeling to personalized drug screening. J Controlled Release. 2021;331:103–120. doi: 10.1016/j.jconrel.2020.12.057
   PubMed Web of Science ®Google Scholar
• Phung YT, Barbone D, Broaddus VC, et al. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J Cancer [Internet]. 2011 [cited 2023 May 16];2:507–514. doi: 10.7150/jca.2.507
   PubMed Web of Science ®Google Scholar
• Huang YL, Ma Y, Wu C, et al. Tumor spheroids under perfusion within a 3D microfluidic platform reveal critical roles of cell-cell adhesion in tumor invasion. Sci Rep [Internet]. 2020. cited 2023 May 16;10(1):1–11. Available from: https://www.nature.com/articles/s41598-020-66528-2. doi: 10.1038/s41598-020-66528-2
   PubMed Web of Science ®Google Scholar
• Kapałczyńska M, Kolenda T, Przybyła W, et al. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Arch Med Sci [Internet]. 2018 [cited 2024 Feb 12];14: 910. Available from: http://pmc/articles/PMC6040128/.
   PubMed Web of Science ®Google Scholar
• Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18(5–6):240–249. doi: 10.1016/j.drudis.2012.10.003
   PubMed Web of Science ®Google Scholar
• Benien P, Swami A. 3D tumor models: history, advances and future perspectives. Future Oncol [Internet]. 2014 [cited 2023 Jun 17];10(7):1311–1327. Available from: https://www.futuremedicine.com/doi/10.2217/fon.13.274
   PubMed Web of Science ®Google Scholar
• Marques IA, Fernandes C, Tavares NT, et al. Magnetic-based human tissue 3D cell culture: a systematic review. IJMS [Internet]. 2022. cited 2024 Feb 13;23(20):12681. Available from: https://www.mdpi.com/1422-0067/23/20/12681/htm. doi: 10.3390/ijms232012681
   Google Scholar
• Ferreira JN, Hasan R, Urkasemsin G, et al. A magnetic three-dimensional levitated primary cell culture system for the development of secretory salivary gland-like organoids. J Tissue Eng Regen Med [Internet]. 2019 [cited 2024 Feb 13];13(3):495–508. doi: 10.1002/term.2809
   PubMed Web of Science ®Google Scholar
• Chan WS, Mo X, Ip PPC, et al. Patient-derived organoid culture in epithelial ovarian cancers—techniques, applications, and future perspectives. Cancer Med [Internet]. 2023 [cited 2024 Feb 13];12(19):19714–19731. doi: 10.1002/cam4.6521
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi W, Kuss M, et al. 3D bioprinting of breast cancer models for drug resistance study. ACS Biomater Sci Eng [Internet]. 2018. cited 2024 Feb 13;4(12):4401–4411. Available from: https://pubs.acs.org/doi/full/10.1021/acsbiomaterials.8b01277. doi: 10.1021/acsbiomaterials.8b01277
   PubMed Web of Science ®Google Scholar
• Yadav B, Pemovska T, Szwajda A, et al. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci Rep [Internet]. 2014. cited 2023 Nov 28;4(1):1–10. Available from: https://www.nature.com/articles/srep05193. doi: 10.1038/srep05193
   Google Scholar
• Thoma CR, Stroebel S, Rösch N, et al. A high-throughput–compatible 3D microtissue co-culture system for phenotypic RNAi screening applications. SLAS Discovery [Internet]. 2013. cited 2023 Jun 19;18(10):1330–1337. Available from: https://pubmed.ncbi.nlm.nih.gov/24080258/. doi: 10.1177/1087057113499071
   Google Scholar
• Zanoni M, Piccinini F, Arienti C, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep [Internet]. 2016 [cited 2023 Jun 19];6(1). Available from: /pmc/articles/PMC4707510/. doi: 10.1038/srep19103
   Google Scholar
• Särchen V, Shanmugalingam S, Kehr S, et al. Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with natural killer (NK) cell-based immunotherapy. Cell Death Discov [Internet]. 2022. cited 2023 Jun 19;8(1):1–10. Available from: https://www.nature.com/articles/s41420-021-00812-6. doi: 10.1038/s41420-021-00812-6
   PubMed Web of Science ®Google Scholar
• Wan C, Keany MP, Dong H, et al. Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high-grade serous ovarian cancer. Cancer Res [Internet]. 2021. cited 2023 Jun 19;81(1):158. Available from: /pmc/articles/PMC7878408/. doi: 10.1158/0008-5472.CAN-20-1674
   PubMed Web of Science ®Google Scholar
• Meng Q, Xie S, Gray GK, et al. Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids. J Immunother Cancer. [Internet] 2021 [cited 2023 Jun 19];9(11):e003213. doi: 10.1136/jitc-2021-003213
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhu M, Meng F, et al. Evaluation of PD-1 blockade using a multicellular tumor spheroid model. Am J Transl Res [Internet]. 2019 [cited 2023 Nov 16];11: 7471. Available from: http://pmc/articles/PMC6943460/.
   PubMed Web of Science ®Google Scholar
• Sirenko O, Mitlo T, Hesley J, et al. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures. Assay Drug Dev Technol [Internet]. 2015. cited 2023 Nov 3;13(7):402. Available from: /pmc/articles/PMC4556086/. doi: 10.1089/adt.2015.655
   PubMed Web of Science ®Google Scholar
• Kast V, Nadernezhad A, Pette D, et al. A tumor microenvironment model of pancreatic cancer to elucidate responses toward immunotherapy. Adv Healthc Mater [Internet] 2023. cited 2023 Jul 28;12(14):2201907. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.202201907. doi: 10.1002/adhm.202201907
   Web of Science ®Google Scholar
• Booij TH, Price LS, Danen EHJ. 3D cell-based assays for drug screens: challenges in imaging, image analysis, and high-content analysis. SLAS DISCOVERY [Internet]. 2019 [cited 2023 Nov 3];24(6):615–627. doi: 10.1177/2472555219830087.
   PubMed Web of Science ®Google Scholar
• Rolver MG, Elingaard-Larsen LO, Pedersen SF. Assessing cell viability and death in 3d spheroid cultures of cancer cells. J Visualized Exp. 2019;2019(148). doi: 10.3791/59714.
   Google Scholar
• Edwards SJ, Carannante V, Kuhnigk K, et al. High-resolution imaging of tumor spheroids and organoids enabled by expansion microscopy. Front Mol Biosci. 2020;7:567282. doi: 10.3389/fmolb.2020.00208
   Web of Science ®Google Scholar
• Diosdi A, Hirling D, Kovacs M, et al. Cell lines and clearing approaches: a single-cell level 3D light-sheet fluorescence microscopy dataset of multicellular spheroids. Data Brief. 2021;36:107090. doi: 10.1016/j.dib.2021.107090
   PubMed Web of Science ®Google Scholar
• Saraiva DP, Matias AT, Braga S, et al. Establishment of a 3D co-culture with MDA-MB-231 breast cancer cell line and patient-derived immune cells for application in the development of immunotherapies. Front Oncol. 2020;10:561826. doi: 10.3389/fonc.2020.01543
   Web of Science ®Google Scholar
• Zhang Z, Wang G, Zhong K, et al. A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy. J Transl Med [Internet]. 2023 [cited 2023 Apr 5];21(1):1–20. doi: 10.1186/s12967-023-03875-4
   PubMed Web of Science ®Google Scholar
• Ruppen J, Cortes-Dericks L, Marconi E, et al. A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids. Lab Chip [Internet]. 2014 [cited 2023 Jun 19];14(6):1198–1205. doi: 10.1039/C3LC51093J
   PubMed Web of Science ®Google Scholar
• Li C, Holman JB, Shi Z, et al. On-chip modeling of tumor evolution: advances, challenges and opportunities. Mater Today Bio. 2023;21:100724. doi: 10.1016/j.mtbio.2023.100724
   PubMedGoogle Scholar
• Li NT, Co IL, Landon-Brace N, et al. Tissue-engineered 3D cancer microenvironment for screening therapeutics. In: Kundu SC, Reis RL, editors. Biomate 3D Tumor Model. Elsevier; 2020. p. 453–479. doi: 10.1016/B978-0-12-818128-7.00019-8
   Google Scholar
• Meindl-Beinker NM, Betge J, Gutting T, et al. A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). BMC Cancer [Internet]. 2019 [cited 2024 Feb 13];19(1). Available from: /pmc/articles/PMC6419339/. doi: 10.1186/s12885-019-5446-2
   PubMedGoogle Scholar
• Snijder B, Vladimer GI, Krall N, et al. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study. 2017 [cited 2023 Nov 5]; Available from: http://www.thelancet.com/haematologyPublishedonline.
   Google Scholar
• Kropivsek K, Kachel P, Goetze S, et al. Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nat Cancer. 2023. cited 2023 Aug 2;4(5):734–753. Available from: https://www.nature.com/articles/s43018-023-00544-9. doi: 10.1038/s43018-023-00544-9
   PubMedGoogle Scholar
• Smiraglia DJ, Rush LJ, Frühwald MC, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Human Molecular Genetics [Internet]. 2001. cited 2023 Nov 5;10(13):1413–1419. Available from: https://pubmed.ncbi.nlm.nih.gov/11440994/. doi: 10.1093/hmg/10.13.1413
   PubMed Web of Science ®Google Scholar
• Pan C, Kumar C, Bohl S, et al. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol & Cell Proteom [Internet]. 2009. cited 2023 Nov 5;8(3):443. Available from: /pmc/articles/PMC2649808/. doi: 10.1074/mcp.M800258-MCP200
   PubMed Web of Science ®Google Scholar
• Li YR, Yu Y, Kramer A, et al. An ex vivo 3D tumor microenvironment-mimicry culture to study TAM modulation of cancer immunotherapy. Cells [Internet]. 2022. cited 2023 Nov 5;11(9):1583. Available from: /pmc/articles/PMC9101510/. doi: 10.3390/cells11091583
   PubMed Web of Science ®Google Scholar
• Lee SH, Hu W, Matulay JT, et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell. 2018;173(2):515–528.e17. doi: 10.1016/j.cell.2018.03.017
   PubMed Web of Science ®Google Scholar
• Grassi L, Alfonsi R, Francescangeli F, et al. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases. Cell Death Dis [Internet]. 2019. cited 2023 Nov 6;10(3):1–15. Available from: https://www.nature.com/articles/s41419-019-1453-0. doi: 10.1038/s41419-019-1453-0
   Google Scholar
• Martini G, Belli V, Napolitano S, et al. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer. ESMO Open. 2023;8(3):101198. doi: 10.1016/j.esmoop.2023.101198
   PubMed Web of Science ®Google Scholar
• Subtil B, Iyer KK, Poel D, et al. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Front Immunol. 2023;14:1105244. doi: 10.3389/fimmu.2023.1105244
   PubMed Web of Science ®Google Scholar
• Longati P, Jia X, Eimer J, et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer [Internet]. 2013 [cited 2023 Jun 18];13(1):1–13. doi: 10.1186/1471-2407-13-95
   PubMedGoogle Scholar
• Ryu NE, Lee SH, Park H. Spheroid culture system methods and applications for mesenchymal stem cells. Cells [Internet]. 2019 [cited 2023 Jun 18];8(12):1620. Available from: https://www.mdpi.com/2073-4409/8/12/1620/htm. doi: 10.3390/cells8121620
   PubMed Web of Science ®Google Scholar
• Białkowska K, Komorowski P, Bryszewska M, et al. Spheroids as a type of three-dimensional cell cultures—examples of methods of preparation and the most important application. Int J Mol Sci [Internet]. 2020. cited 2023 Jun 18;21(17):6225. Available from. https://www.mdpi.com/1422-0067/21/17/6225/htm. doi: 10.3390/ijms21176225
   PubMed Web of Science ®Google Scholar
• Wang T, Wang L, Wang G, et al. Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers. Bioresour Bioprocess [Internet]. 2020. cited 2023 Jun 17;7(1):1–34. Available from: https://bioresourcesbioprocessing.springeropen.com/articles/10.1186/s40643-020-00325-7. doi: 10.1186/s40643-020-00325-7
   Web of Science ®Google Scholar
• Gunti S, Hoke ATK, Vu KP, et al. Organoid and spheroid tumor models: techniques and applications. Cancers (Basel) [Internet]. 2021. cited 2023 Jun 17;13(4):1–18. Available from: /pmc/articles/PMC7922036/. doi: 10.3390/cancers13040874
   Web of Science ®Google Scholar
• Unnikrishnan K, Thomas LV, Ram Kumar RM. Advancement of scaffold-based 3D cellular models in cancer tissue engineering: an update. Front Oncol [Internet]. 2021 [cited 2023 Jun 17];11.Available from: /pmc/articles/PMC8573168/. doi: 10.3389/fonc.2021.733652
   PubMed Web of Science ®Google Scholar